• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应对中国结核病/耐多药结核病的挑战:采取一致行动势在必行。

Tackling challenges of TB/MDRTB in China: concerted actions are imperative.

作者信息

Tang Shenglan

机构信息

Duke Global Health Institute, Duke University, Durham, USA ; Duke Kunshan University, Global Health Research Center, Kunshan, China.

出版信息

Infect Dis Poverty. 2015 Apr 16;4:19. doi: 10.1186/s40249-015-0050-4. eCollection 2015.

DOI:10.1186/s40249-015-0050-4
PMID:25908975
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4407541/
Abstract

China is the second largest TB epidemic with the most number of people infected with multi-drug resistant (MDR). Over the past decade, a large number of TB control projects have been funded by the government of China and international organizations, and epidemic in China has been effectively controlled. However TB control in China still faced many challenges. Strategies to address these challenges may include integrating the national TB control program into health insurance schemes, strengthening TB case management through involving the Chinese hospital in national TB control program, and reforming payment methods for TB care as part of health system reform in China.

摘要

中国是结核病疫情第二严重的国家,耐多药感染者数量最多。在过去十年里,中国政府和国际组织资助了大量结核病控制项目,中国的疫情得到了有效控制。然而,中国的结核病控制仍面临许多挑战。应对这些挑战的策略可能包括将国家结核病控制项目纳入医疗保险计划,通过让中国医院参与国家结核病控制项目来加强结核病病例管理,以及作为中国卫生系统改革的一部分改革结核病治疗的支付方式。

相似文献

1
Tackling challenges of TB/MDRTB in China: concerted actions are imperative.应对中国结核病/耐多药结核病的挑战:采取一致行动势在必行。
Infect Dis Poverty. 2015 Apr 16;4:19. doi: 10.1186/s40249-015-0050-4. eCollection 2015.
2
Multi-source financing for tuberculosis treatment in China: key issues and challenges.中国结核病治疗的多源融资:关键问题与挑战
Infect Dis Poverty. 2021 Mar 10;10(1):17. doi: 10.1186/s40249-021-00809-4.
3
What lessons can be drawn from tuberculosis (TB) control in China in the 1990s? An analysis from a health system perspective.从20世纪90年代中国结核病控制中可以吸取哪些经验教训?从卫生系统角度进行的分析。
Health Policy. 2005 Apr;72(1):93-104. doi: 10.1016/j.healthpol.2004.06.009.
4
[Exogenous re-infection in tuberculosis].[结核病中的外源性再感染]
Kekkaku. 2006 Feb;81(2):79-91.
5
Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force.抗击广泛耐药结核病计划:联邦结核病特别工作组的建议
MMWR Recomm Rep. 2009 Feb 13;58(RR-3):1-43.
6
Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Beijing, China: 2006 versus 2012.中国北京耐多药结核分枝杆菌的流行情况及分子特征:2006年与2012年对比
BMC Microbiol. 2016 May 12;16:85. doi: 10.1186/s12866-016-0699-2.
7
Prevalence of drug resistant Mycobacterium tuberculosis among children in China.中国儿童耐多药结核分枝杆菌的流行情况。
Tuberculosis (Edinb). 2015 May;95(3):315-20. doi: 10.1016/j.tube.2015.02.041. Epub 2015 Feb 21.
8
Anti-tuberculosis drug resistance patterns and trends in a tuberculosis referral hospital, 1997-2009.1997-2009 年结核病转诊医院的抗结核药物耐药模式和趋势。
Epidemiol Infect. 2011 Dec;139(12):1909-18. doi: 10.1017/S0950268810003158. Epub 2011 Jan 27.
9
The burden of MDR/XDR tuberculosis in coastal plains population of China.中国沿海平原地区耐多药/广泛耐药结核病的负担
PLoS One. 2015 Feb 17;10(2):e0117361. doi: 10.1371/journal.pone.0117361. eCollection 2015.
10
[How to cope with the global tuberculosis burden--experiences and perspectives for Japan's international cooperation].[如何应对全球结核病负担——日本国际合作的经验与展望]
Kekkaku. 2005 Feb;80(2):89-94.

引用本文的文献

1
Influence of Public Health Services on the Goal of Ending Tuberculosis: Evidence From Panel Data in China.公共卫生服务对终结结核病目标的影响:来自中国面板数据的证据。
Front Public Health. 2022 Mar 4;10:826800. doi: 10.3389/fpubh.2022.826800. eCollection 2022.
2
Challenges Faced by Multidrug-Resistant Tuberculosis Patients in Three Financially Affluent Chinese Cities.中国三个经济发达城市中耐多药结核病患者面临的挑战
Risk Manag Healthc Policy. 2020 Nov 2;13:2387-2394. doi: 10.2147/RMHP.S275400. eCollection 2020.
3
Utilization and expenses of outpatient services among tuberculosis patients in three Chinese counties: an observational comparison study.中国三个县结核病人门诊服务的利用和费用:一项观察性对比研究。
Infect Dis Poverty. 2019 Oct 4;8(1):79. doi: 10.1186/s40249-019-0590-0.
4
The impact of increased reimbursement rates under the new cooperative medical scheme on the financial burden of tuberculosis patients.新合作医疗方案下提高报销比例对结核病人经济负担的影响。
Infect Dis Poverty. 2019 Aug 2;8(1):67. doi: 10.1186/s40249-019-0575-z.
5
Impact of an innovative financing and payment model on tuberculosis patients' financial burden: is tuberculosis care more affordable for the poor?创新融资和支付模式对结核病患者经济负担的影响:结核病治疗对穷人来说更负担得起吗?
Infect Dis Poverty. 2019 Mar 24;8(1):21. doi: 10.1186/s40249-019-0532-x.
6
Multidrug-resistant tuberculosis in rural China: lack of public awareness, unaffordable costs and poor clinical management.中国农村地区的耐多药结核病:公众意识缺乏、费用负担不起以及临床管理不善。
BMJ Case Rep. 2018 Aug 11;2018:bcr-2018-225794. doi: 10.1136/bcr-2018-225794.
7
Financial barriers and coping strategies: a qualitative study of accessing multidrug-resistant tuberculosis and tuberculosis care in Yunnan, China.经济障碍与应对策略:对中国云南耐多药结核病及结核病医疗服务可及性的定性研究
BMC Public Health. 2017 Feb 22;17(1):221. doi: 10.1186/s12889-017-4089-y.
8
Spatial transmission and meteorological determinants of tuberculosis incidence in Qinghai Province, China: a spatial clustering panel analysis.中国青海省结核病发病率的空间传播及气象决定因素:一项空间聚类面板分析
Infect Dis Poverty. 2016 Jun 2;5(1):45. doi: 10.1186/s40249-016-0139-4.
9
The impact of the new cooperative medical scheme on financial burden of tuberculosis patients: evidence from six counties in China.新型农村合作医疗对肺结核患者经济负担的影响:来自中国六个县的证据。
Infect Dis Poverty. 2016 Jan 28;5:8. doi: 10.1186/s40249-015-0094-5.
10
Disparity in reimbursement for tuberculosis care among different health insurance schemes: evidence from three counties in central China.不同医疗保险计划下结核病治疗报销的差异:来自中国中部三个县的证据。
Infect Dis Poverty. 2016 Jan 27;5:7. doi: 10.1186/s40249-016-0102-4.

本文引用的文献

1
Factors associated with primary transmission of multidrug-resistant tuberculosis compared with healthy controls in Henan Province, China.河南省耐药结核病患者与健康对照者原发性传播的相关因素比较。
Infect Dis Poverty. 2015 Mar 24;4:14. doi: 10.1186/s40249-015-0045-1. eCollection 2015.
2
Factors associated with patient, and diagnostic delays in Chinese TB patients: a systematic review and meta-analysis.与中国结核病患者的患者和诊断延迟相关的因素:系统评价和荟萃分析。
BMC Med. 2013 Jul 2;11:156. doi: 10.1186/1741-7015-11-156.
3
The hospital of the future in China: China's reform of public hospitals and trends from industrialized countries.中国未来的医院:中国公立医院改革及来自工业化国家的趋势
Health Policy Plan. 2014 May;29(3):367-78. doi: 10.1093/heapol/czt023. Epub 2013 Apr 23.
4
National survey of drug-resistant tuberculosis in China.中国耐药结核病国家调查。
N Engl J Med. 2012 Jun 7;366(23):2161-70. doi: 10.1056/NEJMoa1108789.
5
Expanding health insurance coverage in vulnerable groups: a systematic review of options.扩大弱势群体的医疗保险覆盖范围:选项的系统评价。
Health Policy Plan. 2011 Mar;26(2):93-104. doi: 10.1093/heapol/czq038. Epub 2010 Sep 2.